1h Free Analyst Time
Insys Therapeutics Inc (INSY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.Speak directly to the analyst to clarify any post sales queries you may have.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Insys Therapeutics Inc (Insys) is a specialty pharmaceutical company, which discovers, develops and commercializes novel drug delivery systems of therapeutic compounds. The company harnesses its proprietary sublingual spray technology to develop pharmaceutical cannabinoids. Its marketed products inlcude Subsys, a sublingual fentanyl spray for breakthrough cancer pain (BTCP) and Syndros (dronabinol oral solution), an orally administered liquid formulation of dronabinol for the treatment of chemotherapy-induced nausea and vomiting (CINV) and anorexia associated with weight loss in AIDS patients. The company offers its products to oncologists, pain specialists and supportive care centers for the potential treatment of addiction to opioids, opioid overdose and epilepsy. It has operations in the US and offers its products in international markets. Insys is headquartered in Chandler, Arizona, the US.
Insys Therapeutics Inc Key Recent Developments
Mar 25, 2019 INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting
Mar 07, 2019 INSYS Therapeutics reports fourth quarter and full year 2018 results
Jan 09, 2019 INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Section 1 - About the Company- Insys Therapeutics Inc - Key Facts
- Insys Therapeutics Inc - Key Employees
- Insys Therapeutics Inc - Key Employee Biographies
- Insys Therapeutics Inc - Major Products and Services
- Insys Therapeutics Inc - History
- Insys Therapeutics Inc - Company Statement
- Insys Therapeutics Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
Section 2 - Company Analysis
- Company Overview
- Insys Therapeutics Inc - Business Description
- Insys Therapeutics Inc - Corporate Strategy
- Insys Therapeutics Inc - SWOT Analysis
- SWOT Analysis - Overview
- Insys Therapeutics Inc - Strengths
- Insys Therapeutics Inc - Weaknesses
- Insys Therapeutics Inc - Opportunities
- Insys Therapeutics Inc - Threats
- Insys Therapeutics Inc - Key Competitors
Section 3 - Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
- Insys Therapeutics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
- Mar 25, 2019: INSYS Therapeutics to Present Poster of Pharmacokinetic Study of Naloxone Novel Nasal Spray at The College on Problems of Drug Dependence Annual Scientific Meeting
- Mar 07, 2019: INSYS Therapeutics reports fourth quarter and full year 2018 results
- Jan 09, 2019: INSYS Therapeutics Announces Results of Dose-Finding PK Study for Epinephrine Nasal Spray for Treatment of Anaphylaxis
- Nov 05, 2018: INSYS Therapeutics reports third quarter 2018 results
- Nov 01, 2018: INSYS Therapeutics Announces Results of PK Study Assessing Proprietary Intranasal Naloxone Formulations versus Intramuscular and Intravenous Naloxone for Opioid Overdose
- Oct 10, 2018: INSYS Therapeutics names new general counsel
- Oct 01, 2018: INSYS Therapeutics Signs Definitive License Agreement with Lunatus to Commercialize SUBSYS fentanyl sublingual spray in the Middle East
- Sep 04, 2018: INSYS Therapeutics and UC San Diego’s Center for Medicinal Cannabis Research Expand Collaboration to Include Clinical Study of Cannabidiol in Early Psychosis
- Aug 22, 2018: Justice Department takes first-of-its-kind-legal action to reduce opioid over-prescription
Section 6 - Appendix
- Methodology
- Ratio Definitions
- About the Publisher
- Contact Us
- Disclaimer
List of Tables
- Insys Therapeutics Inc, Key Facts
- Insys Therapeutics Inc, Key Employees
- Insys Therapeutics Inc, Key Employee Biographies
- Insys Therapeutics Inc, Major Products and Services
- Insys Therapeutics Inc, History
- Insys Therapeutics Inc, Other Locations
- Insys Therapeutics Inc, Subsidiaries
- Insys Therapeutics Inc, Key Competitors
- Insys Therapeutics Inc, Ratios based on current share price
- Insys Therapeutics Inc, Annual Ratios
- Insys Therapeutics Inc, Annual Ratios (Cont...1)
- Insys Therapeutics Inc, Interim Ratios
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019
- Insys Therapeutics Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
List of Figures
- Insys Therapeutics Inc, Performance Chart (2014 - 2018)
- Insys Therapeutics Inc, Ratio Charts
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019
- Insys Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019
Companies Mentioned
A selection of companies mentioned in this report includes:
- Taisho Pharmaceutical Holdings Co Ltd
- Rohto Pharmaceutical Co Ltd
- Mitsubishi Tanabe Pharma Corp
- Daiichi Sankyo Co Ltd
- Chugai Pharmaceutical Co Ltd
- Astellas Pharma Inc
